期刊文献+

贵定地区23例患者尿路结石成分分析 被引量:2

Analysis of Urinary Calculi Composition in 23 Patients in Guiding Area
下载PDF
导出
摘要 目的探析贵定地区23例患者的尿路结石成分。方法搜集于2015年9月—2018年9月期间在贵定县人民医院泌尿外科接受治疗的23例尿路结石患者作为该次的重点研究对象,并对所有患者采用的经过检验后的尿路结石成分情况给予严密观察,并做好记录和总结。结果通过对两组患者实施不同的实验检测过程中发现,其中草酸钙结石病例中,男性占52.17%,女性占47.83%,且尿路结石的发生部位顺位分别是肾脏占17.39%,输尿管占73.91%,膀胱占8.70%;则检出的草酸钙最为突出,总检出率为95.65%、其次是碳酸磷灰石的总检为43.48%、最后是尿酸及尿酸铵的总检出率分别为21.74%和26.09%。结论贵定地区结石成分以草酸钙为主,其次是碳酸磷灰石、尿酸及尿酸铵。 Objective To analyze the composition of urinary tract stones in 23 patients in Guiding area.Methods Twenty-three patients with urinary calculi who were treated in the urology department of Guiding County People's Hospital from September 2015 to September 2018 were selected as the focus of this study,and all the patients were tested for urinary calculi.The composition of urinary calculi used by all patients was closely observed,recorded and summarized.Results in the two groups of patients with calcium oxalate calculi,52.17% of them were male and 47.83% were female,and the incidence of urinary calculi was 17.39% in kidney,respectively.Ureter 73.91,bladder 8.70%.The total detection rate of calcium oxalate was 95.65%,that of carbonate apatite was 43.48%,and that of uric acid and ammonium uric acid was 21.74% and 26.09%,respectively.Conclusion For the chemical analysis method,the detection rate of urinary tract stones is more ideal by infrared spectroscopy,which is worthy of clinical promotion.
作者 穆林 MU Lin(Guiding County People's Hospital,Guiding,Guizhou Province,551300 China)
出处 《系统医学》 2019年第8期41-43,共3页 Systems Medicine
关键词 贵定地区 尿路结石 成分 分析 Guiding area Urinary calculi Composition Analysis
  • 相关文献

参考文献13

二级参考文献99

  • 1叶章群.泌尿系结石研究现况与展望[J].中华实验外科杂志,2005,22(3):261-262. 被引量:267
  • 2詹皇南,梅骅,王晓波,欧阳颖敏.4714例尿路结石化学成份分析[J].中华实验外科杂志,1995,12(5):316-317. 被引量:37
  • 3张泽,李逊,吴开俊,欧莉莉,雷鸣,戚德峰.尿石症预防饮食管理软件管理肾结石患者饮食摄入的应用价值[J].中华泌尿外科杂志,2007,28(3):186-188. 被引量:33
  • 4LOTAN Y, JIMENEZ IB, LENOIR-WIJNKOOP I, et al. In- creased water intake as a prevention strategy fox" recurrenturolithiasis: major impact of compliance on cost-effectiveness[J]. J Urol, 2013, 189(3): 935-939.
  • 5BEEREPOOT MAJ, GEERLINGS SE, VAN HAARST EP, et al. Nonantibiotic prophylaxis for recurrent urinary tract infections: a systematic review and meta-analysis of randomized controlled tri-Ms[J]. J Urol, 2013, 190(6): 1981-1989.
  • 6IKRAM M, REHMAN S, ALI M, et al. Urease and ct-ehy- motrypsin inhibitory activities of transition metal complexes of new Schiff base ligand: Kinetic and thermodynamic studies of the synthesized complexes using TG-DTA pyrolysis [Jr]. Ther- mochim Acta, 2013, 562: 22-28.
  • 7SALAMA RHM, ALGHASHAM A, morphogenetie protein-2 will be a urinary tract infections and stone 2012, 45(10/11): 766-769. MOSTAFA MS, et al. Bone novel biochemical marker in formation [J]. Clin Biochem,.
  • 8Daudon M, Bouzidi H, Basin D. Composition and morphol ogy of phosphate stones and their relation with etiology [J].Urol Res,2010(38) :459-467.
  • 9Sun XZ,Shen LM,Cong XM, et al. Infrared spectroscopic analysis of 5,248 urinary stones from Chinese patients presenting with the first stone episode [J].Urol Res, 2011,39(5) :339-343.
  • 10Basiri A, Taheri M, Taheri F. What is the state of the stone analysis techniques in urolithiasis[J]. Urol J,2012, 9(2) :445 -454.

共引文献82

同被引文献17

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部